Ani Pharmaceuticals Inc. (ANIP) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Ani Pharmaceuticals Inc. (ANIP:NASDAQ), powered by AI.

Current Price
$83.00
P/E Ratio
21.2
Market Cap
1.7B
Sector
Healthcare
What is the Ani Pharmaceuticals Inc. stock price forecast?

Ani Pharmaceuticals Inc. is currently trading at $83.00. View real-time AI analysis on Alpha Lenz.

What is Ani Pharmaceuticals Inc. insider trading activity?

View the latest insider trading data for Ani Pharmaceuticals Inc. on Alpha Lenz.

What is Ani Pharmaceuticals Inc.'s P/E ratio?

Ani Pharmaceuticals Inc.'s P/E ratio is 21.2.

Ani Pharmaceuticals Inc.

NASDAQ · ANIP
$83.00+0.71(+0.86%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Ani Pharmaceuticals Inc.'s future dividend policy...
Alpha Chat Insight

Ani Pharmaceuticals Inc. trades at a P/E of 21.2 (fair value) with strong ROE of 16.2%. 3Y revenue CAGR of 40.8% highlights clear growth momentum.

Ask for details

Company Overview

Ani Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing, manufacturing, and marketing high-quality generic and branded pharmaceutical products. The company operates primarily within the healthcare sector, addressing niche markets that are often underserved, thus ensuring a vital role in providing alternative options to more expensive treatments. Ani Pharmaceuticals Inc. emphasizes product development and the commercialization of unique therapies, with a growing portfolio that includes both complex generics and branded pharmaceuticals. Their product line covers areas such as endocrinology, oncology, and dermatology, providing critical solutions and serving specialized medical needs. With manufacturing facilities based in the United States, Ani Pharmaceuticals continues to strengthen its market presence through strategic acquisitions and partnerships, holding a significant position in the pharmaceutical industry as a reliable source of vital medications.

CEOMr. Nikhil Lalwani
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees897

Company Statistics

FY 2025

Profile

$1.66BMarket Cap
$883.37MRevenue
0.00Shares Out
897Employees

Margins

61.36%Gross
19.76%EBITDA
9.20%Operating
10.84%Pre-Tax
8.87%Net

Valuation

21.25P/E
3.08P/B
1.88EV/Sales
11.43EV/EBITDA
11.03P/FCF

Growth (CAGR)

40.81%Rev 3Yr
33.48%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

5.75%ROA
16.16%ROE
8.51%ROIC

Financial Health

$285.58MCash & Cash Equivalents
$614.07MNet Debt
166.38%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Ani Pharmaceuticals Inc. (ticker: ANIP) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 897 employees. Market cap is $1.7B.

The current price is $83 with a P/E ratio of 21.25x and P/B of 3.08x.

ROE is 16.16% and operating margin is 9.20%. Annual revenue is $883M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Ani Pharmaceuticals Inc. (ANIP) Stock Forecast 2026 $83.00 — Price, Financials & Analyst Targets | Alpha Lenz